ClinicalTrials.govpublic full text
Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
hodgkin's disease, lymphoma, campath-1h monoclonal antibody, alemtuzumab, campath, campath-1h, relapsed and resistant classical hodgkin's disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900497
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.